Shockwave Therapy for Tennis Elbow
Less painful than surgery
TUESDAY, March 18, 2003 (HealthDayNews) -- The OssaTron high energy orthopedic shockwave device has been approved by the U.S. Food and Drug Administration for treatment of chronic tennis elbow, medically known as lateral epicondylitis.
The device is already agency-approved for heel pain. Manufacturer HealthTronics Surgical Services Inc. says it requires only one treatment, allows for faster recovery, and is less painful than surgery to correct tennis elbow.
FDA approval was based on a 225-patient clinical trial, in which 90 percent of participants benefited from the treatment and 64 percent reported excellent or good outcomes, HealthTronics says in a prepared statement.